Vascular Disease Program
The Vascular Disease Program in the Cardiovascular Research Center is designed to understand, treat and potentially cure carotid artery disease, peripheral artery disease, venous thromboembolism, arterial aneurysm and arterial dissection.
The program is currently:
- Developing AI-aided electrocardiograms to identify pulmonary emboli, increase diagnostic accuracy, improve time to diagnosis, and predict severity and outcomes.
- Evaluating anticoagulation AI models to inform international normalized ratio (INR) management and medicine dosing to improve time in the therapeutic range and decrease the burden on healthcare professionals.
- Discovering the potential for AI analysis of the face in order to screen for and predict cardiovascular diseases.
- Evaluating innovative vascular devices to monitor and diagnose deep vein thrombosis.
- Translating AI models using blood flow characteristics in the leg to better predict cardiovascular conditions and adverse vascular limb outcomes.
- Participating in studies of novel anticoagulants to prevent stroke and systemic embolism to find safer and more-effective solutions for long-term prevention.
- Participating in studies to understand optimal treatment and interventions for chronic leg symptoms after deep vein thrombosis.
- Understanding COVID-19 infection and vaccination-related thrombotic outcomes to inform clinical practice and care.
- Successfully completing a clinical trial on a prolonged novel anticoagulant for cancer-associated venous thromboembolism.